Patient-reported outcomes following total thyroidectomy and lobectomy in thyroid cancer survivors: an analysis of the PROFILES Registry data.
Maaike A G van GerwenPeter V CookeNaomi AlpertFloortje MolsEric GendenRebecca M SchwartzPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Concerns about post-surgical medication use specifically in the TT group may indicate that clinicians should consider LT in patients with low-risk, differentiated thyroid cancer when LT and TT are viable surgical options. Clinicians should be aware of the impact of post-surgical medication use in particular following TT and use this knowledge to align goals of treatment with the extent of surgery, allowing for a better-informed decision-making process.